Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none

Nat Rev Microbiol. 2012 Jan 9;10(2):150-6. doi: 10.1038/nrmicro2712.

Abstract

Some individuals who are infected with HIV rapidly deteriorate shortly after starting antiretroviral therapy, despite effective viral suppression. This reaction, referred to as immune reconstitution inflammatory syndrome (IRIS), is characterized by tissue-destructive inflammation and arises as CD4(+) T cells re-emerge. It has been proposed that IRIS is caused by a dysregulation of the expanding population of CD4(+) T cells specific for a co-infecting opportunistic pathogen. Here, we argue that IRIS instead results from hyper-responsiveness of the innate immune system to T cell help, a mechanism that may be shared by the many manifestations of IRIS that occur following the reversal of other types of immunosuppression in pathogen-infected hosts.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / immunology
  • Animals
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Disease Models, Animal
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / etiology*
  • Immune Reconstitution Inflammatory Syndrome / immunology
  • Immune Tolerance / immunology
  • Immunity, Innate / immunology
  • Immunity, Innate / physiology
  • Lymphopenia / immunology
  • Mice
  • Models, Immunological
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / immunology
  • Natalizumab
  • Risk Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • Natalizumab